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ABSTRACT
Peptide recognition domains and transcription
factors play crucial roles in cellular signaling. They
bind linear stretches of amino acids or nucleotides,
respectively, with high specificity. Experimental
techniques that assess the binding specificity of
these domains, such as microarrays or phage
display, can retrieve thousands of distinct ligands,
providing detailed insight into binding specificity.
In particular, the advent of next-generation
sequencing has recently increased the throughput
of such methods by several orders of magnitude.
These advances have helped reveal the presence
of distinct binding specificity classes that co-exist
within a set of ligands interacting with the same
target. Here, we introduce a software system
called MUSI that can rapidly analyze very large
data sets of binding sequences to determine the
relevant binding specificity patterns. Our pipeline
provides two major advances. First, it can detect
previously unrecognized multiple specificity
patterns in any data set. Second, it offers
integrated processing of very large data sets from
next-generation sequencing machines. The results
are visualized as multiple sequence logos
describing the different binding preferences of the
protein under investigation. We demonstrate the
performance of MUSI by analyzing recent phage
display data for human SH3 domains as well as
microarray data for mouse transcription factors.
INTRODUCTION
The wiring diagram of cellular signaling pathways is
formed by speciﬁc molecular interactions involving
proteins, DNA and other molecules (1,2). Among these,
signaling protein–protein interactions typically consist of
protein domains [such as kinases (3–5), SH3 (6) or PDZ
(7,8)] binding short unstructured regions on their target
proteins. These regions are characterized by very speciﬁc
linear sequence motifs that are recognized by the domain
they bind to. For instance, SH3 domains are known to
target PxxP motifs with a positively charged residue
either on the left (Class I, [R/K]xxPxxP), or on the right
(Class II, PxxP[R/K]) of the proline-rich region (6).
Similarly, DNA binding domains of transcription factors
(TF) make direct contact with short stretches of nucleo-
tides that display high sequence speciﬁcity (9). This speci-
ﬁcity is crucial for enabling proteins to interact selectively
with their cognate partners within the crowded intra-
cellular environment. Detailed understanding of binding
speciﬁcity encoded in these motifs is very powerful to
accurately predict novel interactions (4,10–13) and for
the design of new inhibitor compounds (14).
Various technologies, such as microarrays (12,15,16),
SPOT arrays (17), phospho-proteomics arrays (18), or
phage display (19), have been designed to characterize
the binding speciﬁcity of protein domains and transcrip-
tion factors. Data from these experiments enable compu-
tational models to describe binding speciﬁcity. One
well-known such model is the Position Weight Matrix
(PWM, also known as Position-Speciﬁc Scoring Matrix).
This model has been widely applied to characterize the
binding speciﬁcity of both peptide recognition domains
and transcription factors (20–23). However, several
*To whom correspondence should be addressed. Tel: +41 21 692 4081; Fax: +41 21 692 4065; Email: david.gfeller@isb-sib.ch
Correspondence may also be addressed to Philip M. Kim. Tel: 416-946-3419; Fax: 416-978-8287; Email: pi@kimlab.org
Published online 30 December 2011 Nucleic Acids Research, 2012, Vol. 40, No. 6 e47
doi:10.1093/nar/gkr1294
 The Author(s) 2011. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.recent studies suggest that the use of single PWMs leads to
a reductive view of binding speciﬁcity, since a PWM does
not consider correlations between different ligand
positions (5,16,24,25). To overcome this limitation, differ-
ent strategies have been developed based on neural
networks (5), hidden Markov models (25) or clustering
(24,26). The latter describes binding speciﬁcity with
multiple PWMs corresponding to clusters of ligands that
follow the same speciﬁcity. The results of such analysis can
be readily visualized as multiple sequence logos. Clear
examples of multiple speciﬁcity were encountered in
several peptide recognition domain families (24), as well
as in transcription factors (16).
Most of these computational tools work efﬁciently with
up to a few hundred ligands. However, recent technologic-
al advances have increased the throughput of the afore-
mentioned experimental methods by several orders of
magnitude. In particular, combining the power of phage
display with next-generation sequencing currently enables
the retrieval of thousands of different ligands binding to
the same domain (27,28). This deluge of data represents
both a challenge and an opportunity. On the one hand, it
requires more efﬁcient and faster processing systems. On
the other hand, it enables analysis at greater resolution,
such as distinguishing between different multiple binding
speciﬁcities. Here, we introduce the integrated system
MUltiple Speciﬁcity Identiﬁer (MUSI) that addresses
both these issues, enabling high-throughput analysis of
large data sets and detecting novel multiple speciﬁcity.
MUSI provides a simple interface for processing short
peptide or nucleic acid sequence data. Starting from a
set of sequences observed to bind to a given target, it
automatically generates an optimal number of PWMs
based on the different speciﬁcity patterns present in
the data. The results are graphically displayed in a table
of sequence logos (Figure 1). These are useful for
visualizing the different binding speciﬁcities. The numer-
ical values of the different PWMs are also provided so that
the user can quantitatively compare them, or use them to
predict protein–protein or protein–DNA interactions. We
expect MUSI to be particularly relevant to researchers
working with phage-display, peptide arrays, protein
binding microarrays or similar high-throughput
technologies to map binding speciﬁcity of protein inter-
action domains, RNA-binding proteins or transcription
factors.
MATERIALS AND METHODS
MUSI aims to provide a robust and user-friendly interface
to identify multiple speciﬁcity within a set of sequences
(either peptides or nucleic acids). Usually, these sequences
would share some common property, such as binding to
the same target. The algorithm behind MUSI is based on
the idea of ﬁtting several linear probabilistic models (in
our case, PWMs) to a set of sequences to optimally
describe the different speciﬁcity classes. It relies on the
mathematical tools of mixture models and uses a
Maximum Likelihood approach with Dirichlet priors for
ﬁtting. It accepts a variety of input formats from
raw Illumina sequencing reads (FASTQ) to peptide or
nucleotide sequences in standard FASTA ﬁles. The
program can be executed from the command line or
with a Graphical User Interface (GUI).
Preprocessing of the data
First, a set of N unique sequences is generated
by removing duplicates, since multiple occurrences of the
same sequence are often not very informative in terms of
speciﬁcity and could originate from experimental biases
(e.g. artiﬁcial ampliﬁcation of the same ligand along
experimental procedure). These sequences are then
aligned using MAFFT, a sequence alignment tool (29).
In the case of short ligands binding to a linear epitope,
internal gaps are not very structurally meaningful and
may even prevent relavant speciﬁcities from being distin-
guished. Hence, we use a large gap opening penalty that is
iteratively increased until internal gaps are eliminated.
Both the redundancy removal and alignment steps can
be optionally skipped in MUSI. Special options are avail-
able for FASTQ data pre-processing (described later).
Algorithm
Starting from a set of N aligned sequences, we use a
mixture model to identify multiple PWMs (24). Aligned
sequences are modeled as strings of M letters, taken from
an alphabet of size S (S=20 for proteins and S=4 for
DNA or RNA). In this model, the speciﬁcity is described
with K different PWMs where  k
li corresponds to the prob-
ability of residue or nucleotide i at position l according to
the kth PWM. A weight  
k is also associated with each
PWM. The goal of the algorithm is therefore to identify
the optimal parameters  k
li and  
k. For a given K, this
optimization is carried out using standard Maximum
Likelihood with the Expectation-Maximization (EM)
algorithm (24,26). For each optimization, we generate
10 random initial conﬁgurations (i.e. 10 random assign-
ments of the sequences to K groups) and keep the one that
gives the highest log-likelihood value.
The problem of ﬁnding an optimal value for K is more
challenging and several different methods have been
designed, such as the Bayesian Inference Criterion or
Kolmogorov–Smirnov tests (30). Here, the number of
PWMs is automatically determined by the algorithm in
the following way. Starting from K=1 PWM, we itera-
tively increment K by one and run the mixture model as
described previously. The new conﬁguration with K+1
PWMs is accepted if:
(i) Each PWM has a weight  
k larger than P=0.01
and larger than 5/N (if N>5).
(ii) For any pair of PWMs the Euclidean distance be-
tween the probabilities of at least two positions
is larger than a cut-off distance D.I n
other words, for all (k, k0), k6¼k0, there exist at
least two distinct positions l1 and l2 such that
ð
PS
i¼1 ð k
l1i  k0
l1iÞ
2Þ
0:5 D and ð
PS
i¼1 ð k
l2i  k0
l2iÞ
2Þ
0:5 D.
(iii) K<Kmax
Condition (i) ensures that each speciﬁcity is represented
by the minimal number of sequences in the input data.
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only one or two sequences that most likely result from
sub-optimal maxima in the EM optimization or false-
positives in the experimental data. Condition (ii)
prevents redundancy among the different speciﬁcities
identiﬁed by the algorithm by ensuring that any pair of
PWMs has at least two positions with signiﬁcantly differ-
ent speciﬁcities. This typically results from positional
correlations between these positions, which are known
to underlie multiple speciﬁcity (24). The maximal
number of PWMs (Kmax) in condition (iii) is set to 10 by
default, but can be modiﬁed by the user. To prevent the
algorithm from terminating too early because of criterion
(ii), we chose a relatively small value of D=0.5. As a last
post-processing step, we merge pairs of PWMs with less
than two positions with a Euclidean distance larger than
D0 =0.63. These cut-off values were manually chosen
based on our experience with the method in order to
ensure that multiple PWMs are not redundant. Different
choices for P, D and D0 do not signiﬁcantly affect the per-
formance of the algorithm, as shown in Supplementary
Table S1. Alternatively, the number of PWMs can also
be ﬁxed by the user.
The time complexity of this algorithm scales as
O(NMK) if the number of PWMs is ﬁxed and O(NMK
2)
if it is decided by the algorithm. In particular, it runs much
faster than a previous method (24) that relied on a clus-
tering of the ligands scaling typically as O(N
2). As such it
can be applied to very large data sets consisting of thou-
sands of sequences in a few seconds (see ‘Results’ section).
Output
The results of the mixture model are used to draw
sequence logos corresponding to each speciﬁcity and
these can be displayed in a table such as the one shown
in Figure 1. Additionally, the numerical values of both the
single and multiple PWMs, together with their weights,
can be exported for subsequent analysis, such as genome
or proteome scanning to predict protein–DNA or protein–
protein interactions. For each sequence in the input set, we
also provide its probability with respect to each of the
PWMs (so-called responsibilities). These are useful to
estimate which of the different speciﬁcity classes each
ligand belongs to.
Pipeline requirements
MUSI is written in Perl and C+ +. It uses the Biologically
Relevant Analysis of Interaction Networks (BRAIN)
library, which is built on top of Biojava (31), to generate
Figure 1. General diagram of MUSI describing the steps from sequence ﬁles to multiple sequence logos. With typical FASTA input, MUSI optionally
removes redundant sequences, then runs multiple sequence alignment. It then predicts multiple binding speciﬁcity. Finally, it generates logos (Examples:
Src SH3 domain, and smad3 TF). When handling raw and barcoded sequencing reads (FASTQ) (for multiplexed applications), it begins by ﬁltering
and sorting by barcodes. The red arrows indicate different starting points that can be selected by the user depending on the kind of input data.
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MAFFT (29) to align the sequences. Both are integrated
in the system. The Graphical User Interface (GUI) for
Mac OS X is a Cocoa wrapper for perl scripts, written
in Objective C. For PDF table generation, pdfLaTeX is
required.
The pipeline is available for download (http://www
.kimlab.org/software/musi) and runs locally on most
platforms (Mac OS X, Linux and UNIX, the GUI
version is only available on Mac OS X). Detailed instal-
lation instructions are provided on the website.
Processing raw reads from an Illumina sequencer
A set of special input options is included in MUSI to
process FASTQ sequence data labeled by barcodes.
These features enable straightforward processing of data
obtained from Illumina sequencing. Supplementary
Figure S1 summarizes the different steps described here.
Filtering reads using the Phred quality score. To obtain
high-quality results with minimal noise from sequencing,
the sequences are ﬁltered based on quality scores. To
measure sequencing quality, our system averages the
Phred scores within each sequence (33). Users can select
separate minimum average Phred scores for the sequence,
forward barcode and reverse barcode. This is because the
quality of reads tends to decrease toward the end of each
sequence. The default threshold for all three sections is 25
(99.7% sequencing accuracy)
Sort by barcodes. Multiplexing using barcodes is common-
ly used to make optimal use of sequencing capacity.
Hence, MUSI supports multiplexing, by sorting processed
reads according to a user-supplied list of barcodes. In this
step, the system sorts reads from different barcodes into
separate ﬁles to process many domains at once.
After sorting and ﬁltering, MUSI continues processing
as described earlier for FASTA ﬁles.
Experimental data sets
All sets of nucleotides binding to 305 different transcrip-
tion factors and homeodomains come from three studies
based on protein binding microarrays (16,34,35) and were
downloaded from the UniPROBE website (36). By testing
all possible 8-mers, this technique generates both positive
and negative data. We used a cut-off values of 0.35 on the
enrichment score to deﬁne positives and of  0.3 to deﬁne
negative data, To map the speciﬁcity of the human Src
SH3 domain, we used phage-display technology (19),
where very large libraries of random peptides can be ex-
pressed on the surface of phage particles. The phage
colonies were then sequenced with Illumina deep
sequencing. In this way, a total of 2457 unique peptides
were identiﬁed to bind to Src SH3 domain (raw data for
this domain can be downloaded from http://www.kimlab
.org/software/musi).
Comparison with BEEML
To compare MUSI with BEEML (37), we have down-
loaded intensity information (normalized intensities and
60-mer probe sequences) and seed PWMs from
UniPROBE (36) for each protein from Berger et al. (35).
After running BEEML on each pair of inputs, we have
used the PWMs from BEEML to perform cross-validation
in the same way as cross-validation of PWMs from
UniPROBE.
RESULTS
Cross-validation
To probe the accuracy of the different PWMs generated
by MUSI, we performed standard 10-fold cross-
validation. We used the data from UniPROBE (36) con-
sisting of in vitro DNA sequences binding to different
transcription factors generated with protein binding
microarrays (16,34,35). We split the positives and nega-
tives into 10 groups for cross-validation. The multiple
PWMs were generated with MUSI based on 9 of the 10
groups (training set), and used to compute the score of the
sequences in the last group (testing set). As MUSI does
not incorporate information about negative data sets, only
positive examples were used to build the multiple PWMs.
The procedure was repeated 10 times for each domain,
each time using a different group of positives and nega-
tives for the testing set. Figure 2 shows the average of
Receiver Operating Curve (ROC) over all transcription
factors and all 10 cross-validation runs. We compared
MUSI results with the PWMs generated by the BEEML
method (37), the MEME software (with the maximum
number of motifs set to ﬁve) (38), as well as the ones
provided on the UniPROBE website itself. Both MEME
and UniPROBE methods are able to detect cases of
multiple speciﬁcity. All four methods performed well in
terms of cross-validation, with MUSI still giving statistic-
ally signiﬁcantly higher Area Under the ROC (AUC)
values (Figure 2 and Supplementary Figures S2–S4).
Figure 2. Averaged ROC from 305 test sets [transcription factor
binding sites from (16,34,35)] for 3 algorithms, (MUSI, UniPROBE
and MEME) (Mean AUC: 0.9721, 0.9167 and 0.9192, respectively).
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A crucial requirement for MUSI is to perform efﬁciently
with large data sets. Figure 3 shows the results in CPU
time for different sets of nucleic acids and peptides. Each
point represents either a nucleotide or peptide data set
(MUSI is blue and MEME is red). The CPU time of
MUSI including all steps from redundancy removal and
alignment to logo generation grows linearly with the size
of the input, enabling the processing of tens of thousands
of unique sequences in a short time. Comparison with the
MEME and the method of (24) (Figure 3) as well as
BEEML (Supplementary Figure S4) software shows that
MUSI runs orders of magnitude faster than these two
methods.
Using MUSI as a denoising tool
A common issue with high-throughput experimental
techniques is the high rate of false positives. It is therefore
useful to understand how MUSI performs on noisier data
sets. To investigate this, we used the experimental phage
display data for the human SH3 domain and mixed them
with increasingly higher numbers of randomly generated
peptides (excluding random peptides that by chance were
already present in the initial set). We observed that, in
general, the presence of false-positives yields one addition-
al completely unspeciﬁc PWM (Supplementary Figure S5)
that contains almost all randomly generated peptides.
Using MUSI with longer sequences
Another important issue can arise with the length of the
input sequences, since motifs spread out within long
sequences are much more difﬁcult to automatically
identify. To test this possible limitation, we added
random ﬂanking sequences on both sides of the phage
display peptide data for the human SH3 domain. We
observed that multiple speciﬁcity is correctly detected as
long as the total size of the ﬂanking sequences remains
<40 (Supplementary Figure S6). This clearly exceeds the
size of the motif itself. However, we stress that MUSI
works optimally with sequences that are relatively short
to enable the motifs to be accurately detected.
Human SH3 domain multiple speciﬁcity
The novel phage display data obtained for Src SH3
domain reveal how several interesting features can be
detected with MUSI (Figure 4A). SH3 domains have
long been classiﬁed into two main speciﬁcity classes
summarized with the motifs [R/K]xxPxxP (Class I) and
PxxPx[R/K] (Class II) (6). From biochemical and crystal-
lographic studies, SRC SH3 domain is known to accom-
modate ligands of both classes. This can also be seen in the
multiple speciﬁcity proﬁles of Figure 4A. Interestingly,
SRC SH3 domain binds ASAP1 and this interaction is
critical for the ASAP1 phosphorylation and membrane
trafﬁcking role (39). Although ASAP1 contains several
proline rich regions, only two of them are known to
bind SRC SH3 domains (39). The sequences of these
two regions [(UniProt identiﬁer: Q9ULH1) 791–797:
PPLPPRN and 892–898: RVLPKLP] match exactly the
two speciﬁcity proﬁles predicted by MUSI (see Figure 4a)
and correspond to the two best hits of the multiple PWMs
model along the ASAP1 sequence, while the single
PWM failed to identify the ﬁrst binding site. This
further highlights how careful distinction between differ-
ent speciﬁcities can improve biological insights.
Transcription factor multiple speciﬁcity
MUSI can also detect multiple binding speciﬁcity from
protein binding microarray data on transcription factors
(Figure 4B). For example, Smad3 (Mothers against
decapentaplegic homolog3) is a well-known transcription
factor, which is one of the modulators in the TGF-b sig-
naling pathway (40). The Smad protein family plays an
essential role in the intracellular signaling of transforming
growth factor-b (TGF-b), which initiates various cellular
responses (41). In particular, Smad3 is known to bind
CAGA box [AG(C/A)CAGACA] within the human
PAI-1 promoter as its binding sites, which mediates
TGF-b-transcriptional induction and other down-stream
stimulations (41). Furthermore, its other known binding
motif is a GC-rich motif (42,43). MUSI is able to detect
the two previously reported motifs.
DISCUSSION
Efﬁcient analysis and visualization of large-scale experi-
mental data is a crucial way of gaining novel insights into
biological systems. For large data sets of peptides or nu-
cleotides interacting with proteins, sequence logos enable
very useful and intuitive visualization. Multiple logos,
such as the ones used in (24) and (16) provide a natural
Figure 3. Performance comparison. CPU time for MUSI, MEME and
the method of (24) (blue, red, magenta, respectively) measured on the
standard UNIX system. Genomic data sets (305 in total) from
UniPROBE are used as inputs. Other unpublished proteomic data
sets obtained from phage display (451 different domains) were used
as inputs for MUSI (inset, green points). The number of sequences in
the proteomic data sets varies from 1 (0.59s) to 12323 (301s). The
black curve in the inset represents logged linear curve ﬁtted to MUSI
runtimes for proteomic data sets.
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applied in many instances to better describe the speciﬁcity
of peptide recognition or DNA-binding domains.
With MUSI, we aim to provide a standalone system
for rapidly processing this kind of data. The algorithm
takes standard sequence ﬁles as input and generates
multiple PWMs together with the corresponding graphical
sequence logos. For the use case of mapping peptide
recognition speciﬁcity, MUSI supports a full input pre-
processing stage for standard 96-well plate data labeled
by barcodes. As phage-display technology combined
with next-generation sequencing is currently one of the
most powerful techniques for identifying peptide-binding
motifs, we believe that this tool will be very useful for
researchers in the ﬁeld.
The high efﬁciency and speed of MUSI derives from
new development and optimization of the method initially
proposed in (24). In particular, the replacement of the
clustering step used to identify multiple speciﬁcity with a
mixture model based method to determine the optimal
number of PWMs allowed us to reduce the complexity
of the algorithm from O(N
2MK
2)t oO ( NMK
2), where N
is the number of sequences, M their length and K the
number of PWMs. This enables MUSI to rapidly
process tens of thousands of sequences.
Compared with existing motif discovery tools, such as
YMF (44), and Weeder Web (45), MUSI is optimized for
short ligands and, consequently, it can handle much larger
data sets. As such, it is not designed to identify over-
represented motifs spread out in long sequences, as this is
for instance the case when looking for a motif within long
upstream regions of co-expressed genes. Questions like this
would require more involved and computationally more
expensive strategies, such as Gibbs sampling (46), which
does not easily scale with the current data set size.
This limitation in sequence lengths might prevent straight-
forward application of MUSI on data generated from
ChIP-Seq experiments (47), unless peaks can be deﬁned
at a resolution of 40–50bp or shorter. So, it would be rec-
ommended to pre-process the ChIP-Seq data with peak
ﬁnding algorithms such as QuEST (48) to obtain as short
peaks as possible. However, our tests on different bench-
marks indicate that MUSI can accommodate sequences
that are signiﬁcantly longer than the motif itself. The
observed limit in sequence length (around 40) might also
depend on the motif length. Indeed longer motifs convey
more information and thus are more likely to be correctly
recognized in both the alignment and the mixture model
steps. Yet, since most biologically relevant motifs are quite
short, it is clear that MUSI is particularly suited for experi-
mentaldataconsistingofrelativelyshortsequences,suchas
the ones coming from phage display or protein binding
microarrays.
To summarize, MUSI addresses a need in high-
throughput and high-resolution data analysis capability
thus far missing. By mapping all instances of multiple spe-
ciﬁcity, it is not only useful for predicting better protein
interactions, but reveals some of the fundamental mech-
anisms of encoding speciﬁcity in biological interaction
networks. Moreover its speed and accuracy ensures
that it can be used for new data that will be generated in
future projects relying on high-throughput sequencing.
Applications may range from synthetic data, such as the
one produced with phage display technology, to in vivo
data such as extensive sequencing of variable regions
found on viral proteins, antibodies or T-cell receptors.
We expect MUSI to become increasingly useful as
DNA sequencing and microarray technology continues
to improve and be applied to identify new protein or
DNA binding motifs.
A
B
Figure 4. Example sequence logos. The logo on the left is generated from a single PWM and the logos on the right are generated from multiple
PWMs using MUSI. (A) MUSI output for SH3 domain (Src). Even though a single logo can visualize certain binding speciﬁcity of SH3 domain
(Class I), multiple PWMs using MUSI reveal both class I and class II binding speciﬁcities. (B) MUSI output for Smad3 transcription factor. MUSI
detects two motifs that are already reported in UniPROBE (PWM1 and PWM3) as well as their reverse complements (PWM2 and PWM4).
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Supplementary Data are available at NAR Online:
Supplementary Table 1 and Supplementary Figures 1–6.
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